Resources Client Alerts, News Articles, Blog Posts, & Multimedia Everything you need to know about BMD and the industry
In our self-controlled design, no evidence of increased risk of suicide or suicide attempts following GLP-1 RA initiation was observed, consistent with a French case-time-control study including 1102 patients with suicide attempt or fatal suicide and 5,494 controls from 2013-2021 [31]
We were particularly intrigued to investigate the potential link between incretin-based drugs, such as DPP-4 inhibitors and GLP-1RAs, and pancreatic cancer
September 5th, 2025: Research Suggests GLP-1 Medications May Raise Kidney Cancer Risk Amid Growing Litigation A new study published in JAMA Oncology suggests that GLP-1 receptor agonists such as Ozempic and Mounjaro could increase the risk of kidney cancer, despite appearing to lower the risk of certain other cancers
Products using "GLP-1" terminology are using marketing language aligned with search trends, not describing a verified biological mechanism